1.Mustafa M., Illzam E., Muniandy R., Sharifah A., Nang M., Ramesh B. Herpes simplex virus infections, Pathophysiology and Management. IOSR J. Dent. Med. Sci. 2016;15:85–91. doi: 10.9790/0853-150738591. [DOI] [Google Scholar] 2.Madavaraju K., Koganti R., Volety I., Yadavalli T., Shukla D. Herpes Simplex Virus Cell Entry Mechanisms: An Update. Front. Cell. Infect. Microbiol. 2021;10:617578. doi: 10.3389/fcimb.2020.617578. [DOI] [PMC free article] [PubMed] [Google Scholar] 3.Farooq A.V., Shukla D. Herpes Simplex Epithelial and Stromal Keratitis: An Epidemiologic Update. Surv. Ophthalmol. 2012;57:448–462. doi: 10.1016/j.survophthal.2012.01.005. [DOI] [PMC free article] [PubMed] [Google Scholar] 4.Kaye S., Choudhary A. Herpes simplex keratitis. Prog. Retin. Eye Res. 2006;25:355–380. doi: 10.1016/j.preteyeres.2006.05.001. [DOI] [PubMed] [Google Scholar] 5.Whitley R., Davis E.A., Suppapanya N. Incidence of Neonatal Herpes Simplex Virus Infections in a Managed-Care Population. Sex. Transm. Dis. 2007;34:704–708. doi: 10.1097/01.olq.0000258432.33412.e2. [DOI] [PubMed] [Google Scholar] 6.Mostafa H.H., Thompson T.W., Konen A.J., Haenchen S.D., Hilliard J.G., Macdonald S.J., Morrison L.A., Davido D.J. Herpes Simplex Virus 1 Mutant with Point Mutations in UL39 Is Impaired for Acute Viral Replication in Mice, Establishment of Latency, and Explant-Induced Reactivation. J. Virol. 2018;92:e01654-17. doi: 10.1128/JVI.01654-17. [DOI] [PMC free article] [PubMed] [Google Scholar] 7.Gonçalves B.C., Barbosa M.G.L., Olak A.P.S., Terezo N.B., Nishi L., Watanabe M.A., Marinello P., Rechenchoski D.Z., Rocha S.P.D., Faccin-Galhardi L.C. Antiviral therapies: Advances and perspectives. Fundam. Clin. Pharmacol. 2020;35:305–320. doi: 10.1111/fcp.12609. [DOI] [PMC free article] [PubMed] [Google Scholar] 8.Mlynarczyk-Bonikowska B., Majewska A., Malejczyk M., Mlynarczyk G., Majewski S. Antiviral medication in sexually transmitted diseases. Part I: HSV, HPV. Mini-Rev. Med. Chem. 2013;13:1837–1845. doi: 10.2174/13895575113136660088. [DOI] [PubMed] [Google Scholar] 9.Birkmann A., Zimmermann H. HSV antivirals—current and future treatment options. Curr. Opin. Virol. 2016;18:9–13. doi: 10.1016/j.coviro.2016.01.013. [DOI] [PubMed] [Google Scholar] 10.Evans T.G., Bernstein D.I., Raborn G.W., Harmenberg J., Kowalski J., Spruance S.L. Double-Blind, Randomized, Placebo-Controlled Study of Topical 5% Acyclovir-1% Hydrocortisone Cream (ME-609) for Treatment of UV Radiation-Induced Herpes Labialis. Antimicrob. Agents Chemother. 2002;46:1870–1874. doi: 10.1128/AAC.46.6.1870-1874.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]